ReviewNaunyn-Schmiedeberg's archives of pharmacology2026
Young Investigator Award 2026: Integrative mechanistic insights into YAP/TAZ-mediated angiogenesis and its therapeutic implications.
Review in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Young Investigator Award or "Nachwuchspreis der DGPT" (formerly the Fritz Külz Award) is awarded by the German Society for Experimental and Clinical Pharmacology and Toxicology (Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie e.V./DGPT) to young scientists in recognition of their outstanding work in experimental pharmacology and toxicology. The Young Investigator Award in 2026 was awarded to Dr. Dr. Yohanes Cakrapradipta Wibowo from the Medical Faculty Mannheim of Heidelberg University for his previous PhD research, which was supervised by the late Prof. Dr. Thomas Wieland. In this work, Dr. Wibowo uncovered a new mechanistic insight into angiogenesis and proposed a therapeutic strategy for treating pathological angiogenesis. This article provides an overview of Dr. Wibowo's research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.